Article: It’s happening again: FSD Pharma (HUGE.C) is an insider loaded, overvalued, restrictive mess

Article - Media, Publications

It’s happening again: FSD Pharma (HUGE.C) is an insider loaded, overvalued, restrictive mess

CHRIS PARRY, 31 May 2018

What the hell is in the vodka on Howe Street that all of a sudden every new weed deal is coming out tied in knots that enrich the core crew at the expense of everyone else? We’ve spent three days shining a light on MedMen’s (MMEN.C) terrible go-public structure, which enriches execs at the expense of the company and shareholders, and showers them in bonuses every month, a situation that has led to around $400 million in market cap disintegrating over the last few days. Sure, In Vancouver we’re used to deals where insiders are loaded with literal penny (or ha’penny) stock before they even announce what’s going into their shell, and we know that’s one of the costs of doing business on the Venture Exchange – that those early guys will blow their cheap paper out and the company will face pressure as a result.
Continue reading “Article: It’s happening again: FSD Pharma (HUGE.C) is an insider loaded, overvalued, restrictive mess”

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?